ZimVie (ZIMV) Competitors $13.49 +0.32 (+2.43%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ZIMV vs. MDXG, AORT, ESTA, PLSE, BLFS, BVS, CBLL, EYE, FNA, and LQDAShould you be buying ZimVie stock or one of its competitors? The main competitors of ZimVie include MiMedx Group (MDXG), Artivion (AORT), Establishment Labs (ESTA), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), Bioventus (BVS), CeriBell (CBLL), National Vision (EYE), Paragon 28 (FNA), and Liquidia (LQDA). These companies are all part of the "medical equipment" industry. ZimVie vs. MiMedx Group Artivion Establishment Labs Pulse Biosciences BioLife Solutions Bioventus CeriBell National Vision Paragon 28 Liquidia ZimVie (NASDAQ:ZIMV) and MiMedx Group (NASDAQ:MDXG) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, community ranking, valuation and profitability. Is ZIMV or MDXG more profitable? MiMedx Group has a net margin of 23.86% compared to ZimVie's net margin of -77.31%. MiMedx Group's return on equity of 26.21% beat ZimVie's return on equity.Company Net Margins Return on Equity Return on Assets ZimVie-77.31% 2.90% 1.17% MiMedx Group 23.86%26.21%18.15% Does the MarketBeat Community prefer ZIMV or MDXG? MiMedx Group received 42 more outperform votes than ZimVie when rated by MarketBeat users. Likewise, 81.82% of users gave MiMedx Group an outperform vote while only 18.75% of users gave ZimVie an outperform vote. CompanyUnderperformOutperformZimVieOutperform Votes318.75%Underperform Votes1381.25% MiMedx GroupOutperform Votes4581.82% Underperform Votes1018.18% Do insiders and institutionals have more ownership in ZIMV or MDXG? 95.6% of ZimVie shares are owned by institutional investors. Comparatively, 79.2% of MiMedx Group shares are owned by institutional investors. 3.0% of ZimVie shares are owned by insiders. Comparatively, 1.3% of MiMedx Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts prefer ZIMV or MDXG? ZimVie currently has a consensus price target of $18.33, indicating a potential upside of 35.90%. MiMedx Group has a consensus price target of $12.00, indicating a potential upside of 32.45%. Given ZimVie's higher possible upside, equities research analysts plainly believe ZimVie is more favorable than MiMedx Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ZimVie 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00MiMedx Group 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor ZIMV or MDXG? In the previous week, MiMedx Group had 9 more articles in the media than ZimVie. MarketBeat recorded 9 mentions for MiMedx Group and 0 mentions for ZimVie. ZimVie's average media sentiment score of 0.51 beat MiMedx Group's score of 0.50 indicating that ZimVie is being referred to more favorably in the media. Company Overall Sentiment ZimVie Positive MiMedx Group Positive Which has more volatility & risk, ZIMV or MDXG? ZimVie has a beta of 2.14, meaning that its stock price is 114% more volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.94, meaning that its stock price is 94% more volatile than the S&P 500. Which has stronger valuation & earnings, ZIMV or MDXG? MiMedx Group has lower revenue, but higher earnings than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZimVie$457.43M0.81-$393.28M-$13.11-1.03MiMedx Group$321.48M4.14$58.23M$0.5516.47 SummaryMiMedx Group beats ZimVie on 12 of the 18 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get ZimVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ZIMV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZIMV vs. The Competition Export to ExcelMetricZimVieDental equipment & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$363.48M$1.11B$5.07B$8.89BDividend YieldN/A1.81%4.99%4.07%P/E Ratio-1.037.5783.5712.93Price / Sales0.811.171,220.3088.33Price / Cash2.7410.7839.4636.25Price / Book0.922.146.936.25Net Income-$393.28M-$33.08M$119.12M$225.93M7 Day Performance-2.10%3.95%-1.83%-1.32%1 Month Performance-5.00%-7.46%-3.64%0.60%1 Year Performance50.89%134.51%31.64%26.23% ZimVie Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZIMVZimVie2.5824 of 5 stars$13.49+2.4%$18.33+35.9%+49.2%$363.48M$457.43M-1.032,600MDXGMiMedx Group3.1237 of 5 stars$9.06-1.9%$12.00+32.5%+26.4%$1.36B$321.48M16.47895AORTArtivion1.9824 of 5 stars$27.16+0.9%$31.00+14.1%+92.4%$1.13B$354M0.001,500Positive NewsESTAEstablishment Labs2.1311 of 5 stars$41.81+11.4%$60.60+44.9%+90.0%$1.05B$165.15M0.00960High Trading VolumePLSEPulse Biosciences1.5329 of 5 stars$16.14-5.3%N/A+157.8%$1.05B$700,000.000.00140Positive NewsBLFSBioLife Solutions0.8729 of 5 stars$25.01+11.5%$27.50+10.0%+86.5%$1.04B$143.27M0.00409Analyst ForecastInsider TradeAnalyst RevisionBVSBioventus2.7241 of 5 stars$11.41-1.6%$13.00+13.9%+195.6%$940.58M$512.34M29.721,200Positive NewsCBLLCeriBellN/A$25.06-2.0%$31.20+24.5%N/A$916.03MN/A0.00N/AQuiet Period ExpirationAnalyst RevisionHigh Trading VolumeEYENational Vision3.0614 of 5 stars$11.34+0.5%$14.00+23.5%-42.1%$888.30M$2.13B-56.7013,998Positive NewsFNAParagon 282.1583 of 5 stars$10.35-1.4%$15.60+50.7%-0.3%$879.06M$216.39M-13.99343,000Analyst RevisionLQDALiquidia3.7431 of 5 stars$10.12-0.4%$24.00+137.2%+55.7%$859.91M$17.49M0.0050Analyst Revision Related Companies and Tools Related Companies MiMedx Group Competitors Artivion Competitors Establishment Labs Competitors Pulse Biosciences Competitors BioLife Solutions Competitors Bioventus Competitors CeriBell Competitors National Vision Competitors Paragon 28 Competitors Liquidia Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZIMV) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZimVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZimVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZIMV Stock Alerts